The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

ATRA FINANCIAL STATEMENTS

Atara Biotherapeutics Inc — balance sheet, income statement and cash flow trends

ATRAAtara Biotherapeutics Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0200 M400 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue5 M $Gross Profit4.5 M $ · 89%Operating Income-14.2 M $ · -282%Pre-tax Income-16.7 M $ · -330%Net Income to Owners-16.7 M $ · -331%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue5 M $-97.3%
Gross Profit4.5 M $-97.1%
Operating Income-14.2 M $-277.0%
EBITDA-13.8 M $-196.4%
Net Income to Owners-16.7 M $-388.0%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M600 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets21 M
  • Current Liabilities6.8 M $12%
  • Long-term Liabilities51.2 M $88%

Key Figures

YoY change
Total Assets21 M $-43.0%
Total Liabilities58 M $-19.4%
Total Equity-37 M $—
Cash & ST Investments9.9 M $-55.8%
Total Debt8.8 M $-50.3%
Net Debt5.6 M $+626.9%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-20 M-10 M0-21.9 M $Operating-607 K $Investing8.8 M $Financing-13.7 M $Net Change

Key Figures

YoY change
Operating Cash Flow-21.9 M $—
Capital Expenditures0 $-100.0%
Free Cash Flow-21.9 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on ATRA

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.